Form 4 holding
Interim Chief Executive Officer, Director
Peak Bio, Inc.
- Security class
- Common Stock
- Shares / value
- 19,850
- Estimated value
- $5,260
- Report date
- 27 Sep 2023
- Price
- $0.2650
- Ownership
- Direct
Dr. Stephen LaMond
Insider Reports History
- Reporting-owner location
- Palo Alto, CA
- Latest reporting-owner signature
-
/s/ Dr. Stephen LaMond
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Dr. Stephen LaMond
Insider Reports Filed by Dr. Stephen LaMond
4
Peak Bio, Inc.
- Report period
- 26 Sep 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 28 Sep 2023, 16:05
- Role
- Interim Chief Executive Officer, Director
- Next action
- Open filing details
4/A
Peak Bio, Inc.
- Report period
- 15 Sep 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 28 Sep 2023, 16:05
- Role
- Interim Chief Executive Officer, Director
- Next action
- Open filing details
4
Peak Bio, Inc.
- Report period
- 01 Nov 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 03 Nov 2022, 21:52
- Role
- Interim Chief Executive Officer, Chief Operating Officer and Secretary, Director
- Next action
- Open filing details
3
Peak Bio, Inc.
- Report period
- 01 Nov 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 03 Nov 2022, 21:48
- Role
- Interim Chief Executive Officer, Chief Operating Officer and Secretary Exhibit 24 - Power of Attorney, Director
- Next action
- Open filing details